Approval · Notice of Compliance 16404 · 2014
PRISTIQ: Notice of Compliance 16404
Issued December 5, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16404
- Date
- December 5, 2014
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To include pediatric data in the product monograph
- Therapeutic class
- Antidepressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRISTIQ | Not yet assigned | — |
Medicinal ingredients
- DESVENLAFAXINE SUCCINATE 50 MG per TAB
- DESVENLAFAXINE SUCCINATE 100 MG per TAB